Skip to main content
. 2022 Oct;26(10):1115–1119. doi: 10.5005/jp-journals-10071-24338

Table 4.

Initial hs-CRP and outcome of treatment with NIV

NIV treatment group n Initial hs-CRP (mean ± SD) p-value
Success 55 45.88 ± 31.494 <0.001
Failure 49 226.74 ± 97.651